Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.980
-0.280 (-12.39%)
Nov 21, 2024, 12:38 PM EST - Market open

Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $99.22 million. The enterprise value is -$57.33 million.

Market Cap 99.22M
Enterprise Value -57.33M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

Cabaletta Bio has 48.88 million shares outstanding. The number of shares has increased by 29.67% in one year.

Current Share Class 48.88M
Shares Outstanding 48.88M
Shares Change (YoY) +29.67%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 3.10%
Owned by Institutions (%) 87.69%
Float 41.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.63
P/TBV Ratio 0.63
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.11, with a Debt / Equity ratio of 0.09.

Current Ratio 8.11
Quick Ratio 8.00
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -62.16% and return on invested capital (ROIC) is -40.36%.

Return on Equity (ROE) -62.16%
Return on Assets (ROA) -37.89%
Return on Capital (ROIC) -40.36%
Revenue Per Employee n/a
Profits Per Employee -$1.01M
Employee Count 103
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.75% in the last 52 weeks. The beta is 2.42, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y) 2.42
52-Week Price Change -88.75%
50-Day Moving Average 4.08
200-Day Moving Average 10.19
Relative Strength Index (RSI) 23.57
Average Volume (20 Days) 1,316,132

Short Selling Information

The latest short interest is 3.71 million, so 7.58% of the outstanding shares have been sold short.

Short Interest 3.71M
Short Previous Month 3.78M
Short % of Shares Out 7.58%
Short % of Float 8.92%
Short Ratio (days to cover) 4.26

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -114.50M
Pretax Income -89.98M
Net Income -104.16M
EBITDA -112.92M
EBIT -114.50M
Earnings Per Share (EPS) -$2.16
Full Income Statement

Balance Sheet

The company has $183.01 million in cash and $15.22 million in debt, giving a net cash position of $167.79 million or $3.43 per share.

Cash & Cash Equivalents 183.01M
Total Debt 15.22M
Net Cash 167.79M
Net Cash Per Share $3.43
Equity (Book Value) 174.24M
Book Value Per Share 3.57
Working Capital 162.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.55 million and capital expenditures -$2.02 million, giving a free cash flow of -$83.57 million.

Operating Cash Flow -81.55M
Capital Expenditures -2.02M
Free Cash Flow -83.57M
FCF Per Share -$1.71
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.67%
Shareholder Yield -29.67%
Earnings Yield -94.30%
FCF Yield -75.65%

Analyst Forecast

The average price target for Cabaletta Bio is $28.50, which is 1,303.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $28.50
Price Target Difference 1,303.94%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1